Our advocacy work focuses on equity: making sure people with Type1  Diabetes have access to care by tackling issues like systemic racism, financial privilege, and discrimination in all its forms. High quality, modern insulin must be available to people with type1 diabetes regardless of employment or insurance status, across all demographics, without barriers and at an affordable and predictable price point.